PIN16 COST-EFFECTIVENESS OF CEFTAZIDIME-AVIBACTAM + METRONIDAZOLE AS A FIRST-LINE TREATMENT IN PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS IN TAIWAN

Autor:	F.Y.S. Hsiao, Y.C. Wen, W. Furnback, H.M. Chen, S.W. Lin, Y. Chen, C. Charbonneau, S.T. Huang, Bruce Wang
Rok vydání:	2019
Předmět:	medicine.medical_specialty Cost effectiveness business.industry Health Policy Abdominal Infection Public Health Environmental and Occupational Health Ceftazidime/avibactam First line treatment Metronidazole Internal medicine medicine In patient business medicine.drug
Zdroj:	Value in Health. 22:S642-S643
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::81c6d194344a6abfb2fe5b4c7bfea295 https://doi.org/10.1016/j.jval.2019.09.1261 Zobrazit plný text záznamu Full Text from ScienceDirect